To decrease the side effects of spinal anaesthesia using different doses of drugs in Caesarean sectio
Phase 4
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: 1- ObstetricsHealth Condition 3: 1- Obstetrics
- Registration Number
- CTRI/2022/04/041776
- Lead Sponsor
- Rajendra Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient consent
2.Age group - 21years to 40years scheduled for elective caesarean section
3.singleton pregnancy
4.Weight -40 to 80 kg
5.Height- 140cm-170cm
5.ASA II
Exclusion Criteria
1.patient refusal
2.patient with contraindication to spinal anaesthesia
3.patient with cardiovascular disease,pre eclampsia,eclampsia and systolic BP <90 mmHg
4.Women with fetal abnormalities
5.women with placental abnormalities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Incidence of maternal hypotension <br/ ><br>2.Time to reach T8 sensory level <br/ ><br>3.Maximum sensory level achieved and time to reach the same <br/ ><br>4.Time taken for 2 segment sensory regression <br/ ><br>5.Time to achieve modified bromage score 3 <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 24 hrs
- Secondary Outcome Measures
Name Time Method 1.Total dose of mephentermine consumption <br/ ><br>2.APGAR score at 1 and 5 min <br/ ><br>3.To study side effects such as nausea, vomiting ,headacheTimepoint: 24 hrs